Phathom Pharmaceuticals Inc logo

Phathom Pharmaceuticals Inc share price today

(PHAT)

Phathom Pharmaceuticals Inc share price is $8.5 & ₹719.47 as on 6 Dec 2024, 2.30 'hrs' IST

$8.5

-0.45

(-5.03%)

Market is closed - opens 8 PM, 06 Dec 2024

View live Phathom Pharmaceuticals Inc share price in Dollar and Rupees. Guide to invest in Phathom Pharmaceuticals Inc from India. Also see the sentimental analysis on Indian investors investing in Phathom Pharmaceuticals Inc. Get details on the Indian mutual funds that are investing in Phathom Pharmaceuticals Inc. Get Analyst recommendations and forecasts along with all the Phathom Pharmaceuticals Inc's financials.

Phathom Pharmaceuticals Inc share price movements

  • $8.48
    $9.10

    Day's Volatility :6.81%

  • $6.07
    $19.71

    52 Weeks Volatility :69.23%

Phathom Pharmaceuticals Inc Returns

PeriodPhathom Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
-52.03%
-5.7%
0.0%
6 Months
-19.81%
-0.8%
0.0%
1 Year
2.91%
9.9%
0.0%
3 Years
-55.4%
10.7%
-19.7%

Phathom Pharmaceuticals Inc Key Statistics

in dollars & INR

Previous Close
$8.95
Open
$8.95
Today's High
$9.1
Today's Low
$8.48
Market Capitalization
$581.2M
Today's Volume
$769.1K
52 Week High
$19.71
52 Week Low
$6.065
Revenue TTM
$26.3M
EBITDA
$-287.1M
Earnings Per Share (EPS)
$-5.74
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-3489.0%

How to invest in Phathom Pharmaceuticals Inc from India?

It is very easy for Indian residents to invest directly in Phathom Pharmaceuticals Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Phathom Pharmaceuticals Inc stock in both rupees (INR) and dollars (USD). Search for Phathom Pharmaceuticals Inc or PHAT on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Phathom Pharmaceuticals Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Phathom Pharmaceuticals Inc shares which would translate to 0.100 fractional shares of Phathom Pharmaceuticals Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Phathom Pharmaceuticals Inc

138%

Period: Sep 6, 2024 to Dec 5, 2024. Change in 30 Days versus previous period

Search volume for Phathom Pharmaceuticals Inc on INDmoney from India has grown in the last 30 days as on Dec 6, 2024. 138% more investors are searching Phathom Pharmaceuticals Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Phathom Pharmaceuticals Inc

  • Medicxi Ventures Management (Jersey) Ltd

    10.92%

  • Jennison Associates LLC

    8.58%

  • Amvescap Plc.

    5.99%

  • The Carlyle Group Inc

    5.11%

  • BlackRock Inc

    4.28%

  • Vanguard Group Inc

    3.94%

Analyst Recommendation on Phathom Pharmaceuticals Inc

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Phathom Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
11
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Phathom Pharmaceuticals Inc

What analysts predicted

Upside of 192.44%

Current:

$8.50

Target:

$24.86

Insights on Phathom Pharmaceuticals Inc

  • Vs ALNY

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 43.9% return, outperforming this stock by 43.5%
  • Vs VRTX

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 42.3% return, outperforming this stock by 96.9%

Phathom Pharmaceuticals Inc Technicals Summary

Sell

Neutral

Buy

Phathom Pharmaceuticals Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Phathom Pharmaceuticals Inc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Phathom Pharmaceuticals Inc
-52.78%
-19.81%
2.91%
-55.4%
-63.28%
Regeneron Pharmaceuticals, Inc.
-5.97%
-23.44%
-9.57%
20.91%
110.02%
Biontech Se
11.44%
18.44%
16.6%
-60.74%
309.79%
Alnylam Pharmaceuticals, Inc.
-7.77%
64.82%
42.06%
39.68%
108.61%
Vertex Pharmaceuticals Incorporated
-6.83%
-4.79%
29.94%
124.11%
109.65%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Phathom Pharmaceuticals Inc
NA
NA
NA
-4.69
-34.89
-0.58
NA
-2.74
Regeneron Pharmaceuticals, Inc.
18.56
18.56
1.12
44.92
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.06
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.21
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Phathom Pharmaceuticals Inc
Buy
$581.2M
-63.28%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$82.9B
110.02%
18.56
33.61%
Biontech Se
Buy
$28.5B
309.79%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$32.7B
108.61%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$118.4B
109.65%
32.84
-4.51%

About Phathom Pharmaceuticals Inc

phathom pharmaceuticals, inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. the company has the rights in the united states, europe, and canada to vonoprazan, a potassium-competitive acid blocker (p-cab) that blocks acid secretion in the stomach. it is also developing vonoprazan, which is in phase iii clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of helicobacter pylori infection. the company was incorporated in 2018 and is based in buffalo grove, illinois.
Organization
Phathom Pharmaceuticals Inc
Employees
452
CEO
Ms. Terrie J. Curran
Industry
Health Technology

Management People of Phathom Pharmaceuticals Inc

NameTitle
Ms. Terrie J. Curran
President, CEO & Director
Mr. David A. Socks
Co-Founder & Director
Dr. Azmi Nabulsi M.D., M.P.H.
Co-Founder & COO
Ms. Molly Henderson CPA, MBA
Chief Financial & Business Officer
Dr. Aditya Kohli Ph.D.
Co-Founder
Mr. Paul Cocja
Chief People Officer
Mr. Tom Harris
Chief Development Sciences Officer
Dr. Eckhard Leifke M.D., Ph.D.
Chief Medical Officer
Mr. Martin J. Gilligan
Chief Commercial Officer

Important FAQs about investing in Phathom Pharmaceuticals Inc from India :

What is Phathom Pharmaceuticals Inc share price today?

Phathom Pharmaceuticals Inc (PHAT) share price today is $8.50.

Can Indians buy Phathom Pharmaceuticals Inc shares?

Yes, Indians can invest in the Phathom Pharmaceuticals Inc (PHAT) from India.

With INDmoney, you can buy Phathom Pharmaceuticals Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Phathom Pharmaceuticals Inc at zero transaction cost.

How can I buy Phathom Pharmaceuticals Inc shares from India?

It is very easy to buy Phathom Pharmaceuticals Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Phathom Pharmaceuticals Inc be purchased?

Yes, you can buy fractional shares of Phathom Pharmaceuticals Inc with INDmoney app.

What are the documents required to start investing in Phathom Pharmaceuticals Inc stocks?

To start investing in Phathom Pharmaceuticals Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Phathom Pharmaceuticals Inc

Today’s highest price of Phathom Pharmaceuticals Inc (PHAT) is $9.10.

Today’s lowest price of Phathom Pharmaceuticals Inc (PHAT) is $8.48.

What is today's market capitalisation of Phathom Pharmaceuticals Inc

Today's market capitalisation of Phathom Pharmaceuticals Inc PHAT is 581.2M

What is the 52 Week High and Low Range of Phathom Pharmaceuticals Inc

  • 52 Week High

    $19.71

  • 52 Week Low

    $6.07

How much percentage Phathom Pharmaceuticals Inc is down from its 52 Week High?

Phathom Pharmaceuticals Inc (PHAT) share price is $8.50. It is down by 99% from its 52 Week High price of $19.71.

How much percentage Phathom Pharmaceuticals Inc is up from its 52 Week low?

Phathom Pharmaceuticals Inc (PHAT) share price is $8.50. It is up by 1% from its 52 Week Low price of $6.07.

What are the historical returns of Phathom Pharmaceuticals Inc?

  • 1 Month Returns

    -52.78%

  • 3 Months Returns

    -19.81%

  • 1 Year Returns

    2.91%

  • 5 Years Returns

    -63.28%

Who is the Chief Executive Officer (CEO) of Phathom Pharmaceuticals Inc

Ms. Terrie J. Curran is the current Chief Executive Officer (CEO) of Phathom Pharmaceuticals Inc.